Schneck; Jonathan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schneck; Jonathan.The latest application filed is for "artificial t-cell stimulating matrix for immunotherapy".

Company Profile

7.12.21

Schneck; Jonathan - Baltimore MD
Schneck; Jonathan - Silver Spring MD
Schneck; Jonathan - Blatimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Artificial T-cell Stimulating Matrix For Immunotherapy App 20220168442 - Schneck; Jonathan ; et al.	2022-06-02
Reagents And Methods For Identifying, Enriching, And/or Expanding Antigen-specific T Cells App 20210252121 - Schneck; Jonathan ; et al.	2021-08-19
Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells Grant 10,987,412 - Schneck , et al. April 27, 2	2021-04-27
Artificial Antigen Presenting Cells Having A Defined And Dynamic Shape App 20210046008 - Green; Jordan J. ; et al.	2021-02-18
Production Of Antigen-specific T-cells App 20200291381 - OELKE; Mathias ; et al.	2020-09-17
Artificial antigen presenting cells having a defined and dynamic shape Grant 10,758,487 - Green , et al. Sep	2020-09-01
Biodegradable Biomimetic Particles App 20200230257 - Green; Jordan J. ; et al.	2020-07-23
Nanoscale Artificial Antigen Presenting Cells App 20200095546 - Schneck; Jonathan ; et al.	2020-03-26
Antigen-Specific T cell redirectors Grant 10,463,750 - Schneck , et al. No	2019-11-05
Nanoscale artificial antigen presenting cells Grant 10,435,668 - Schneck , et al. O	2019-10-08
Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells Grant 10,098,939 - Schneck , et al. October 16, 2	2018-10-16
Reagents And Methods For Identifying, Enriching, And/or Expanding Antigen-specific T Cells App 20180043003 - Schneck; Jonathan ; et al.	2018-02-15
Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors App 20170261497 - Schneck; Jonathan ; et al.	2017-09-14
Reagents And Methods For Identifying, Enriching, And/or Expanding Antigen-specific T Cells App 20170246277 - Schneck; Jonathan ; et al.	2017-08-31
Nanoscale Artificial Antigen Presenting Cells App 20160051698 - Schneck; Jonathan ; et al.	2016-02-25
Antigen-specific T Cell Redirectors App 20150366991 - Schneck; Jonathan ; et al.	2015-12-24
Artificial Antigen Presenting Cells Having A Defined And Dynamic Shape App 20140370099 - Green; Jordan J. ; et al.	2014-12-18
Molecular Complexes Which Modify Immune Responses App 20120141482 - Schneck; Jonathan ; et al.	2012-06-07
Compositions And Methods For Inducing An Immune Response Against Influenza Antigens App 20110300168 - Schneck; Jonathan ; et al.	2011-12-08
Diagnostic And Treatment Methods For Cancer Based On Immune Inhibitors App 20110256147 - Oelke; Mathias ; et al.	2011-10-20
Molecular Complexes Which Modify Immune Responses App 20110243967 - Schneck; Jonathan ; et al.	2011-10-06
Cell compositions comprising molecular complexes that modify immune responses Grant 7,973,137 - Schneck , et al. July 5, 2	2011-07-05
Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors App 20100008920 - Schneck; Jonathan ; et al.	2010-01-14
Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses App 20040204565 - Schneck, Jonathan ; et al.	2004-10-14
Reagents and methods for engaging unique clonotypic lymphocyte receptors App 20040115216 - Schneck, Jonathan ; et al.	2004-06-17
Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses Grant 6,734,013 - Schneck , et al. May 11, 2	2004-05-11
Molecular complexes which modify immune responses Grant 6,458,354 - Schneck , et al. October 1, 2	2002-10-01
Soluble divalent and multivalent heterodimeric analogs of proteins App 20020127231 - Schneck, Jonathan ; et al.	2002-09-12
Soluble divalent and multivalent heterodimeric analogs of proteins Grant 6,448,071 - Schneck , et al. September 10, 2	2002-09-10
Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses App 20020006903 - Schneck, Jonathan ; et al.	2002-01-17
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses Grant 6,268,411 - Schneck , et al. July 31, 2	2001-07-31
Polynucleotides encoding molecular complexes which modify immune responses Grant 6,140,113 - Schneck , et al. October 31, 2	2000-10-31
Soluble divalent and multivalent heterodimeric analogs of proteins Grant 6,015,884 - Schneck , et al. January 18, 2	2000-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.